ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 108 filers reported holding ADICET BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $441,351 | -57.8% | 181,626 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $1,046,166 | -35.6% | 181,626 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $1,623,736 | -37.1% | 181,626 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $2,583,000 | -2.6% | 181,626 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $2,651,000 | -26.9% | 181,626 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $3,627,000 | +14.2% | 181,626 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $3,176,000 | +123.0% | 181,626 | 0.0% | 0.00% | +100.0% |
Q3 2021 | $1,424,000 | -23.8% | 181,626 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,869,000 | -21.3% | 181,626 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $2,375,000 | -6.9% | 181,626 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $2,552,000 | +18.2% | 181,626 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $2,159,000 | – | 181,626 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |